⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28488779 | 0.97 | — | — | |
| Hydrochloric Acid SCHEMBL27651142 | 0.97 | — | — | |
| Hydrochloric Acid SCHEMBL28297432 | 0.91 | — | — | |
| Benzene SCHEMBL28096982 | 0.69 | — | — | |
| SCHEMBL5653901 | 0.67 | — | — | |
| SCHEMBL27331102 | 0.67 | — | — | |
| SCHEMBL27676732 | 0.67 | — | — | |
| SCHEMBL28096555 | 0.67 | — | — | |
| SCHEMBL30507521 | 0.67 | — | — | |
| SCHEMBL28229477 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112094234-B | Synthesis method of 6-phenyl-2, 3,4, 7-tetrahydro-1H-3-azepine derivative | 山东理工大学 | 2023-07-07 | — | — | CN | claimed |
| CN-112094234-A | Synthetic method of 6-phenyl-2, 3,4, 7-tetrahydro-1H-3-azepinol derivative | 山东理工大学 | 2020-12-18 | — | — | CN | claimed |
| US-4241060-A | FOR SENSITIZING HYPOXIC CELLS TO RADIATION; ANTIPROTOZAL AGENTS | HOFFMANN-LA ROCHE INC. (US) | 1980-12-23 | — | — | US | claimed |
| CN-112521364-B | Galanthamine intermediate compound V | 鲁南制药集团股份有限公司 | 2023-09-05 | — | — | CN | disclosed |
| CN-112521395-B | Preparation method of galanthamine | 鲁南制药集团股份有限公司 | 2023-09-05 | — | — | CN | disclosed |
| CN-112094234-B | Synthesis method of 6-phenyl-2, 3,4, 7-tetrahydro-1H-3-azepine derivative | 山东理工大学 | 2023-07-07 | — | — | CN | disclosed |
| CN-112094234-B | Synthesis method of 6-phenyl-2, 3,4, 7-tetrahydro-1H-3-azepine derivative | 山东理工大学 | 2023-07-07 | — | — | CN | disclosed |
| CN-110003214-B | Substituted pyrazolo [1,5-a ] pyrimidine compounds as TRK kinase inhibitors | 阵列生物制药公司 | 2021-12-21 | — | — | CN | disclosed |
| CN-112094234-A | Synthetic method of 6-phenyl-2, 3,4, 7-tetrahydro-1H-3-azepinol derivative | 山东理工大学 | 2020-12-18 | — | — | CN | disclosed |
| WO-2020230718-A1 | GENETICALLY MODIFIED MICROORGANISM FOR PRODUCING 3-HYDROXYHEXANEDIOIC ACID, (E)-HEX-2-ENEDIOIC ACID AND/OR HEXANEDIOIC ACID, AND PRODUCTION METHOD FOR SAID CHEMICALS | 東レ株式会社 | 2020-11-19 | — | — | WO | disclosed |
| CN-110214136-A | Pyrazole derivatives as MALT1 inhibitor | 詹森药业有限公司 | 2019-09-06 | — | — | CN | disclosed |
| WO-2000015610-A1 | THE PREPARATION OF N-SUBSTITUTED-HYDROXYCYCLOALKYLAMINE DERIVATIVES | SAMSUNG FINE CHEMICALS CO., LTD. (KR) | 2000-03-23 | — | — | WO | disclosed |
| CN-1044814-C | Process for stabilizing trivalent phosphorus compounds with amines | CIBA SC HOLDING AG (CH) | 1999-08-25 | — | — | CN | disclosed |
| US-5708168-A | FOR TREATING OR PREVENTING NEURONAL LOSS | STATE OF OREGON, ACTING BY AND THROUGH THE OREGON STATE BOARD OF HIGHER EDUCATION, ACTING FOR AND ON BEHALF OF THE OREGON HEALTH SCIENCES UNIVERSITY AND THE UNIVERSITY OF OREGON, EUGENE OREGON (US) | 1998-01-13 | — | — | US | disclosed |
| US-5674866-A | Antiallergic imidazoazepines | JANSSEN PHARMACEUTICA N.V. (BE) | 1997-10-07 | — | — | US | disclosed |
| WO-1996015112-A1 | AZEPINE SYNTHESIS VIA A DIELS-ALDER REACTION | ACEA PHARMACEUTICALS, INC. (US) | 1996-05-23 | — | — | WO | disclosed |
| US-5476933-A | Condensation, ring expansion | STATE OF OREGON, ACTING BY AND THROUGH THE OREGON STATE BOARD OF HIGHER EDUCATION, ACTING FOR AND ON BEHALF OF THE OREGON HEALTH SCIENCES UNIVERSITY AND THE UNIVERSITY OF OREGON (US) | 1995-12-19 | — | — | US | disclosed |
| EP-0350051-A1 | Thaz derivatives for enhancemet of cerebral function | Bristol-Myers Squibb Company (US) | 1990-01-10 | — | — | EP | disclosed |
| US-4859666-A | THAZ derivatives for enhancement of cerebral function | BRISTOL-MYERS COMPANY (US) | 1989-08-22 | — | — | US | disclosed |
| CN-85101404-A | The production process of cephalosporins derivatives | — | 1987-01-17 | — | — | CN | disclosed |